REQUEST A DEMO
Total
USD $0.00
Search more companies

Eneo Pharmaceuticals S. R. O. (Czech Republic)

Main Activities: Research and Development in Nanotechnology | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Eneo Pharmaceuticals S. R. O. Profile Updated: August 26, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Eneo Pharmaceuticals S. R. O. is a company based in Czech Republic, with its head office in Stribrna Skalice. The enterprise operates in the Research and Development in Nanotechnology industry. Eneo Pharmaceuticals S. R. O. was incorporated on January 01, 2000. The total number of employees is currently 25 - 49 (2024). From the latest financial highlights, Eneo Pharmaceuticals S. R. O. reported a net sales revenue increase of 3.13% in 2025. A growth of 23.43% was recorded in its total assets. The net profit margin of Eneo Pharmaceuticals S. R. O. increased by 2.36% in 2025.

Headquarters
Prazska 442
Stribrna Skalice; Stredocesky; Postal Code: 28167

Contact Details: Purchase the Eneo Pharmaceuticals S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Eneo Pharmaceuticals S. R. O. report to view the information.
Registered Capital:
Purchase the Eneo Pharmaceuticals S. R. O. report to view the information.
Financial Auditors:
Purchase the Eneo Pharmaceuticals S. R. O. report to view the information.
Incorporation Date:
January 01, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Eneo Pharmaceuticals S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
3.13%
Total Operating Revenue
2%
Operating Profit
9.52%
EBITDA
12.99%
Net Profit/Loss for the Period
45.7%
Total Assets
23.43%
Total Equity
100.18%
Operating Profit Margin
0.61%
Net Profit Margin
2.36%
Return on Equity (ROE)
-27.14%
Debt / Equity
-243.02%
Quick Ratio
-0.21%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?